天眼查App显示，近日，医联医通（上海）贸易有限公司成立，法定代表人为郭春荣，注册资本5万人 民币，经营范围为一般项目：货物进出口；第二类医疗器械销售；第二类医疗设备租赁；软件开发；电 子元器件制造；技术进出口；进出口代理；报关业务；报检业务。（除依法须经批准的项目外，凭营业 执照依法自主开展经营活动）自主展示（特色）项目：第一类医疗器械销售；第一类医疗设备租赁；机 械零件、零部件销售；机械电气设备销售；技术服务、技术开发、技术咨询、技术交流、技术转让、技 术推广；租赁服务（不含许可类租赁服务）；信息咨询服务（不含许可类信息咨询服务）；计算机软硬 件及辅助设备零售；软件销售；办公设备耗材销售；电气设备销售；专用设备修理；电气设备修理；仪 器仪表销售。 ...

Group 1 - The company announced the acquisition of 40% equity in Liaoning Guoke Hengtai Medical Technology Co., Ltd. from Shenyang Qianfu Yu Trading Partnership, which will result in the company holding 100% of the equity after the acquisition [1] - The initial valuation of the equity asset is set at 3.7658 million yuan, with the final price not exceeding the assessment results provided by the evaluation agency and the results filed with the state-owned property management authority [1] - The board of directors approved the acquisition without the need for a shareholders' meeting, indicating that the decision falls within the board's authority [1]

Group 1 - The Shanghai tax authority has implemented tax collection service measures to enhance the level of openness in the Pudong New Area, effectively stimulating foreign trade and investment vitality [1] - In the first half of the year, Pudong New Area processed export tax refunds exceeding 40 billion yuan, a year-on-year increase of 14.2%, and offshore trade stamp duty exemptions exceeded 200 million yuan, benefiting 1,300 enterprises [1] - The foreign reinvestment deferred tax amount increased by 208.5% year-on-year, indicating a significant boost in foreign investment activities [1] Group 2 - In the biopharmaceutical sector, Pudong New Area has pioneered the implementation of a tax policy for small enterprises seeking FDA certification, aiding small and medium-sized pharmaceutical companies in enjoying overseas certification fee exemptions [2] - The FDA certification tax policy has already benefited eight pharmaceutical companies, accelerating the internationalization of the biopharmaceutical industry in Pudong New Area [2] - The Shanghai tax authority aims to continue leveraging its tax functions to support stable foreign investment and trade through the implementation of 11 measures [2]

Group 1 - Company Yanguang Health Management is acquiring an 18.0% stake in Shanghai Ronggong Company from Fanghou No.1 [1] - The company will also subscribe for an additional 9.58% stake in Shanghai Ronggong through a capital increase agreement, with a total investment of RMB 12.72 million [1] - Following the completion of the capital increase, Yanguang Health Management will hold a total of 25.9% of Shanghai Ronggong [1] Group 2 - Yanguang Health Management is purchasing a 51.0% stake in Wuhan Ronggong for RMB 5.1 million, which will make Wuhan Ronggong a subsidiary of the company [2] - Shanghai Ronggong focuses on providing innovative financial technology solutions in the medical industry through its self-developed SaaS platform [2] - Wuhan Ronggong is involved in the wholesale and retail of various medical devices and has a significant market presence in the medical supply chain [2] Group 3 - The company aims to become a diversified imaging service provider for the entire medical imaging industry chain [3] - The strategic integration with Shanghai Ronggong and Wuhan Ronggong is expected to enhance the company's reach and create more business opportunities [3] - The acquisitions will enrich the company's financial tools and business models, promoting innovative solutions in imaging services [3]